Today: March 26, 2017, 10:51 pm

New Market Report Now Available: Sunovion Pharmaceuticals Inc. - Strategic SWOT Analysis Review

Fast Market Research recommends "Sunovion Pharmaceuticals Inc. - Strategic SWOT Analysis Review" from GlobalData, now available 2014-03-28 12:03:34
Sunovion Pharmaceuticals Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.


* Business description - A detailed description of the company's operations and business divisions.
* Corporate strategy - GlobalData's summarization of the company's business strategy.
* SWOT analysis - A detailed analysis of the company's strengths, weakness, opportunities and threats.
* Company history - Progression of key events associated with the company.
* Major products and services - A list of major products, services and brands of the company.
* Key competitors - A list of key competitors to the company.
* Key employees - A list of the key executives of the company.
* Executive biographies - A brief summary of the executives' employment history.
* Key operational heads - A list of personnel heading key departments/functions.
* Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.
* Key manufacturing facilities - A list of key manufacturing facilities of the company.

Full Report Details at
- ..


Sunovion Pharmaceuticals Inc. (Sunovion), formerly, Sepracor Inc., is a research- based pharmaceutical company. The company discovers, develops and commercializes therapeutic products that focus on the treatment of central nervous system and respiratory disorders. Its product portfolio includes xopenex inhalation solution, xopenex HFA Metered-Dose aerosol Inhaler (MDI), arformoterol tartrate inhalation solution, eszopiclone tablets, ciclesonide nasal spray and ciclesonide HFA inhalation aerosol.

Sunovion Pharmaceuticals Inc. Key Recent Developments

Oct 04, 2013: Sunovion Launches Second Annual Community Service Day to Give Back to Greater Boston Communities and Support Causes Nationwide
Mar 28, 2013: Sunovion Pharma Selects BioPharm Systems's Siebel Clinical Trial Management System Accelerator To Facilitate Fully Outsourced Clinical Trial Management Model

Reasons to Get this Report

* Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
* Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services and business strategy.
* Understand and respond to your competitors' business structure and strategies with GlobalData's detailed SWOT analysis. In this, the company's core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
* Examine potential investment and acquisition targets with this report's detailed insight into the company's strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 - About the Company
Sunovion Pharmaceuticals Inc. - Key Facts
Sunovion Pharmaceuticals Inc. - Key Employees
Sunovion Pharmaceuticals Inc. - Key Employee Biographies
Sunovion Pharmaceuticals Inc. - Major Products and Services
Sunovion Pharmaceuticals Inc. - Pharmaceutical Pipeline Products Data
Sunovion Pharmaceuticals Inc., Pipeline Products by Therapy Area
Sunovion Pharmaceuticals Inc., Pipeline Products by Development Phase
Sunovion Pharmaceuticals Inc. - History
Sunovion Pharmaceuticals Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 - Company Analysis
Sunovion Pharmaceuticals Inc. - Business Description
Sunovion Pharmaceuticals Inc. - Corporate Strategy
Sunovion Pharmaceuticals Inc. - SWOT Analysis
SWOT Analysis - Overview
Sunovion Pharmaceuticals Inc. - Strengths
Strength - Wide Product Portfolio
Strength - Broadening of Business Portfolio
Strength - Synergy with Dainippon Sumitomo Pharma Co., Ltd.
Sunovion Pharmaceuticals Inc. - Weaknesses
Weakness - Patent Infringement Claims
Sunovion Pharmaceuticals Inc. - Opportunities
Opportunity - New Product Development
Opportunity - Market for CNS Disorders & Respiratory Conditions
Opportunity - Rising Healthcare Expenditure in the US
Sunovion Pharmaceuticals Inc. - Threats
Threat - Uncertain R&D Outcomes
Threat - Highly Competitive Environment
Threat - Changes in Healthcare Regulations
Sunovion Pharmaceuticals Inc. - Key Competitors
Section 3 - Company's Lifesciences Financial Deals and Alliances
Sunovion Pharmaceuticals Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Sunovion Pharmaceuticals Inc., Pharmaceuticals & Healthcare, Deals By Type, 2008 to YTD 2014
Sunovion Pharmaceuticals Inc., Medical Equipment, Deals By Year, 2008 to YTD 2014
Sunovion Pharmaceuticals Inc., Medical Equipment, Deals By Type, 2008 to YTD 2014
Sunovion Pharmaceuticals Inc., Recent Deals Summary
Section 4 - Company's Recent Developments
Sunovion Pharmaceuticals Inc., Recent Developments
Oct 04, 2013: Sunovion Launches Second Annual Community Service Day to Give Back to Greater Boston Communities and Support Causes Nationwide
Section 5 - Appendix

Full Table of Contents is available at:

About GlobalData

GlobalData is a leading provider of global business intelligence including market, competitor, product and customer information. It provides in-depth research, analysis, data and forecasts through a range of interactive online databases, reports and management briefings. GlobalData has a large team of experienced research and analysis, consulting, and marketing experts. It has a global presence, including key offices in the US, Europe and Asia. The group has over 50 years of experience of delivering market intelligence data and analysis and a highly experienced senior management team. View more research from GlobalData at

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

Press Information

Published by
Bill Thompson

# 968 Words
Related Articles
More From Health
New dynamics in monitoring diagnostics in leukemia
Dresden/Germany Diagnosis leukemia and stem cell transplantation The diagnosis "leukemia" for patients means to undergo [..]
PromarkerD Predictive Diagnostics for DKD to Roll-out [..]
PERTH, AUSTRALIA, Mar 22, 2017 - (ACN Newswire) - Proteomics International Laboratories Ltd ('PILL'; ASX: PIQ), a world leader [..]
Do Prostalgene Drops Help To Restore Prostate [..]
Prostate enlargement is among the most common health problems for men over 50. With age the incidence of this condition [..]
Is OnycoSolve Spray The Key To Obliterating [..]
Toenail fungus is an undesirable but stubborn infection that comes with sweating, itching, cracking and scaling of the feet, inflammations, [..]
New Research reveals Asia poised as Preferred [..]
SYDNEY, Mar 10, 2017 - (ACN Newswire) - Frost & Sullivan has released its latest white paper, 'Asia: Preferred Destination for [..]

Disclaimer: If you have any questions regarding information in this press release please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims the content included in this release.